» Articles » PMID: 37055512

Shared and Distinct Abnormalities in Sleep-wake Patterns and Their Relationship with the Negative Symptoms of Schizophrenia Spectrum Disorder Patients

Abstract

Sleep and rest-activity-rhythm (RAR) abnormalities are commonly reported in schizophrenia spectrum disorder (SSD) patients. However, an in-depth characterization of sleep/RAR alterations in SSD, including patients in different treatment settings, and the relationship between these alterations and SSD clinical features (e.g., negative symptoms) is lacking. SSD (N = 137 altogether, N = 79 residential and N = 58 outpatients) and healthy control (HC) subjects (N = 113) were recruited for the DiAPAson project. Participants wore an ActiGraph for seven consecutive days to monitor habitual sleep-RAR patterns. Sleep/rest duration, activity (i.e., M10, calculated on the 10 most active hours), rhythm fragmentation within days (i.e., intra-daily variability, IV; beta, steepness of rest-active changes), and rhythm regularity across days (i.e., inter-daily stability, IS) were computed in each study participant. Negative symptoms were assessed in SSD patients with the Brief Negative Symptom Scale (BNSS). Both SSD groups showed lower M10 and longer sleep/rest duration vs. HC, while only residential patients had more fragmented and irregular rhythms than HC. Compared to outpatients, residential patients had lower M10 and higher beta, IV and IS. Furthermore, residential patients had worse BNSS scores relative to outpatients, and higher IS contributed to between-group differences in BNSS score severity. Altogether, residentials and outpatients SSD had both shared and unique abnormalities in Sleep/RAR measures vs. HC and relative to one another, which also contributed to the patients' negative symptom severity. Future work will help establish whether improving some of these measures may ameliorate the quality of life and clinical symptoms of SSD patients.

Citing Articles

Digital sleep phenotype and wrist actigraphy in individuals at clinical high risk for psychosis and people with schizophrenia spectrum disorders: a systematic review and meta-analysis.

Aronica R, Ostinelli E, Austin C, Oliver D, McGuire P, Brambilla P BMJ Ment Health. 2025; 28(1).

PMID: 39929600 PMC: 11815447. DOI: 10.1136/bmjment-2024-301337.


A systematic review of passive data for remote monitoring in psychosis and schizophrenia.

Bladon S, Eisner E, Bucci S, Oluwatayo A, Martin G, Sperrin M NPJ Digit Med. 2025; 8(1):62.

PMID: 39870797 PMC: 11772847. DOI: 10.1038/s41746-025-01451-2.


Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations.

Vita A, Barlati S, Cavallaro R, Mucci A, Riva M, Rocca P Front Psychiatry. 2024; 15:1451832.

PMID: 39371908 PMC: 11450451. DOI: 10.3389/fpsyt.2024.1451832.


Investigating Rhythmicity in App Usage to Predict Depressive Symptoms: Protocol for Personalized Framework Development and Validation Through a Countrywide Study.

Ahmed M, Hasan T, Islam S, Ahmed N JMIR Res Protoc. 2024; 13:e51540.

PMID: 38657238 PMC: 11079771. DOI: 10.2196/51540.


Relationship between rest-activity rhythms and cardiorespiratory fitness in middle-aged workers: a cross-sectional study with non-parametric analysis using accelerometers worn on the thigh.

Seol J, So R, Murai F, Matsuo T BMC Public Health. 2024; 24(1):62.

PMID: 38166824 PMC: 10763488. DOI: 10.1186/s12889-023-17580-w.


References
1.
Ferrarelli F . Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps. Am J Psychiatry. 2021; 178(10):903-913. PMC: 8446088. DOI: 10.1176/appi.ajp.2020.20070968. View

2.
Laursen T, Wahlbeck K, Hallgren J, Westman J, Osby U, Alinaghizadeh H . Life expectancy and death by diseases of the circulatory system in patients with bipolar disorder or schizophrenia in the Nordic countries. PLoS One. 2013; 8(6):e67133. PMC: 3691116. DOI: 10.1371/journal.pone.0067133. View

3.
Henderson D, Vincenzi B, Andrea N, Ulloa M, Copeland P . Pathophysiological mechanisms of increased cardiometabolic risk in people with schizophrenia and other severe mental illnesses. Lancet Psychiatry. 2015; 2(5):452-464. DOI: 10.1016/S2215-0366(15)00115-7. View

4.
Vancampfort D, Probst M, Knapen J, Carraro A, De Hert M . Associations between sedentary behaviour and metabolic parameters in patients with schizophrenia. Psychiatry Res. 2012; 200(2-3):73-8. DOI: 10.1016/j.psychres.2012.03.046. View

5.
Schmitt A, Maurus I, Rossner M, Roh A, Lembeck M, von Wilmsdorff M . Effects of Aerobic Exercise on Metabolic Syndrome, Cardiorespiratory Fitness, and Symptoms in Schizophrenia Include Decreased Mortality. Front Psychiatry. 2019; 9:690. PMC: 6308154. DOI: 10.3389/fpsyt.2018.00690. View